Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer
Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis
|3||Not yet recruiting||
Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis
† Study has passed its completion date and status has not been verified in more than two years.